EUCTR2007-003187-22-DE进行中（未招募）1 期
HD18 for advanced stages in Hodgkins Lymphoma
niversity of Cologne0 个研究点目标入组 1,600 人开始时间: 2007年12月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
HD18 for advanced stages in Hodgkins Lymphoma - HD18EUCTR2007-003187-22-CZniversity of Cologne2,101
进行中（未招募）
1 期
HD16 for early stages in Hodgkins LymphomaHodgkin´s Lymphomaearly stageEUCTR2007-004474-24-DEniversity of Cologne1,150
进行中（未招募）
不适用
HD 17 for intermediate stage Hodgkin lymphoma: randomised treatment based on results of FDG-PET scaHodgkin Lymphoma intermediate stageMedDRA version: 14.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2007-005920-34-NLVU University Medical Center1,100
进行中（未招募）
1 期
HD17 for Intermediate Stage Hodgkin Lymphoma - Treatment Optimization Trial in the First-Line Treatment of intermediate Stage Hodgkin lymhoma; Therapy stratification by means of FDG-PET - HD17Hodgkin Lymphoma intermediate stageMedDRA version: 20.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2007-005920-34-DEniversity of Cologne1,100
已完成
3 期
HD17 for Intermediate Stage Hodgkin Lymphoma - Treatment Optimization Trial in the First-Line Treatment of intermediate Stage Hodgkin lymhoma; Therapy stratification by means of FDG-PETHodgkin's Disease10025319malignant lymphomaNL-OMON47350Vrije Universiteit Medisch Centrum30